Pharmafile Logo
Pharmafocus logo
Advanced Search

RedHill Biopharma

Showing 4 posts of 4 posts found.

opaganib-bottle-and-tablets

RedHill Biopharma to expand COVID-19 opaganib trial to US

February 24, 2021
Research and Development COVID-19, RedHill Biopharma

RedHill Biopharma has announced its plans to expand the company’s global Phase II/III study of opaganib in patients with severe …

News

RedHill enters manufacturing deal with Cosmo for two key products

February 19, 2021
Medical Communications RedHill Biopharma

RedHill Biopharma has announced agreements with Cosmo Pharmaceuticals to manufacture two of RedHill’s key products. Cosmo will manufacture Movantik, RedHill’s …

News
opaganib-bottle-and-tablets

RedHill expands manufacturing capacity for opaganib with Cosmo

January 29, 2021
Medical Communications RedHill Biopharma

RedHill Biopharma has announced a manufacturing agreement with Cosmo Pharmaceuticals to further expand manufacturing capacity for opaganib (Yeliva), to address …

News
fda2outsideweb

FDA approves RedHill Biopharma’s Talicia to combat Helicobacter pylori infection

November 4, 2019
Sales and Marketing FDA, RedHill Biopharma, pharma

RedHill Biopharma is celebrating after the FDA chose to award marketing authorisation to Talicia (omeprazole magnesium, amoxicillin and rifabutin) for …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025